Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMKJL5T)

Drug Name
Heteroaromatic ring derivative 3 Drug Info
Synonyms PMID28447479-Compound-18
Cross-matching ID
TTD Drug ID
DMKJL5T

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Extracellular lysophospholipase D (E-NPP2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cudetaxestat DMYLDN9 Idiopathic pulmonary fibrosis CB03.4 Phase 2 [2]
PMID28447479-Compound-24 DMDOVIZ N. A. N. A. Patented [1]
Tetra-hydro-carboline derivative 2 DMXTL7V N. A. N. A. Patented [1]
PMID28447479-Compound-14 DMA91X2 N. A. N. A. Patented [1]
Pyrimidinone derivative 5 DMLFY57 N. A. N. A. Patented [1]
Pyrazolo[3,4-c]pyridine derivative 1 DMQHCDZ N. A. N. A. Patented [1]
Pyrazole derivative 87 DMGZUAY N. A. N. A. Patented [1]
Pyridine and pyrimidine derivative 1 DMGEYJW Fibrosis GA14-GC01 Patented [1]
Imidazopyrimidinone derivative 1 DMWN17V N. A. N. A. Patented [1]
PMID28447479-Compound-21 DM8PET6 N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Extracellular lysophospholipase D (E-NPP2) TTSCIM2 ENPP2_HUMAN Inhibitor [1]

References

1 Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829.
2 An updated patent review of autotaxin inhibitors (2017-present). Expert Opin Ther Pat. 2021 May;31(5):421-434.